Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Karolina Partheen
Observed names:
K Partheen,
K. Partheen,
KAROLINA PARTHEEN,
Partheen K
Observed institutions:
Sahlgrenska University Hospital,
University of Gothenburg
OpenAlex ID:
A5024668795
Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass
2011
·
Karolina Partheen
, Björg Kristjansdottir
, et al.
·
Journal of Gynecologic Oncology
·
87
PDF
Four potential biomarkers as prognostic factors in stage III serous ovarian adenocarcinomas
2008
·
Karolina Partheen
, Kristina Levan
, et al.
·
International Journal of Cancer
·
79
Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer
2013
·
Björg Kristjansdottir
, Kristina Levan
, et al.
·
Gynecologic Oncology
·
75
Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors
2006
·
Karolina Partheen
, Kristina Levan
, et al.
·
European Journal of Cancer
·
55
Analysis of cytogenetic alterations in stage III serous ovarian adenocarcinoma reveals a heterogeneous group regarding survival, surgical outcome, and substage
2004
·
Karolina Partheen
, Kristina Levan
, et al.
·
Genes Chromosomes and Cancer
·
47
PDF
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
2009
·
Lovisa Österberg
, Kristina Levan
, et al.
·
BMC Cancer
·
44
PDF
Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ
2013
·
Björg Kristjansdottir
, Kristina Levan
, et al.
·
Clinical Proteomics
·
36
PDF
Ovarian cyst fluid is a rich proteome resource for detection of new tumor biomarkers
2012
·
Björg Kristjansdottir
, Karolina Partheen
, et al.
·
Clinical Proteomics
·
36
PDF
Cytogenetic analysis of carboplatin resistance in early-stage epithelial ovarian carcinoma
2005
·
Lovisa Österberg
, Kristina Levan
, et al.
·
Cancer Genetics and Cytogenetics
·
34
Chromosomal alterations in 98 endometrioid adenocarcinomas analyzed with comparative genomic hybridization
2006
·
K. Levan
, K. Partheen
, et al.
·
Cytogenetic and Genome Research
·
28
External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas
2009
·
Karolina Partheen
, Kristina Levan
, et al.
·
BMC Cancer
·
20
PDF
Identification of a Gene Expression Signature for Survival Prediction in Type I Endometrial Carcinoma
2010
·
KRISTINA LEVAN
, KAROLINA PARTHEEN
, et al.
·
Gene Expression
·
19
Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas
2006
·
Lovisa Österberg
, Margaretha Åkeson
, et al.
·
Cancer Genetics and Cytogenetics
·
19
Early inflammatory response in epithelial ovarian tumor cyst fluids
2014
·
Björg Kristjánsdóttir
, Karolina Partheen
, et al.
·
Cancer Medicine
·
17
PDF
High-Resolution Genomic Profiling of Carboplatin Resistance in Early-Stage Epithelial Ovarian Carcinoma
2009
·
L. Österberg
, K. Levan
, et al.
·
Cytogenetic and Genome Research
·
17
Specific copy number alterations associated with docetaxel/carboplatin response in ovarian carcinomas.
2010
·
Lovisa Osterberg
, Kristina Levan
, et al.
·
PubMed
·
11
BAC CGH-array identified specific small-scale genomic imbalances in diploid DMBA-induced rat mammary tumors
2012
·
Emma Samuelson
, Sara Karlsson
, et al.
·
BMC Cancer
·
9
PDF
Tumor cure probability during alpha-RIT of ovarian cancer with different radiation sensitivity.
2010
·
J Elgqvist
, B R Johansson
, et al.
·
PubMed
·
5
A serum biomarker panel including kallikreins to predict ovarian cancer prognosis and response to chemotherapy
2008
·
Karolina Partheen
, Karin Sundfeldt
·
Expert Review of Obstetrics & Gynecology
New Prognostic Markers in Stage III Serous Ovarian Adenocarcinomas
2008
·
Karolina Partheen
·
Gothenburg University Publications Electronic Archive (Gothenburg University)
PDF
075 Cytogenetic Analysis of Ovarian Carcinoma Regarding Carboplatin Resistance
2004
·
L. Osterberg
, K. Levan
, et al.
·
International Journal of Gynecological Cancer
Genetic Alterations in Ovarian Carcinoma Stage III
2003
·
K. Partheen
, K. Levan
, et al.
·
International Journal of Gynecological Cancer
Show more works
View as search
Works count:
25
Citation count:
638
H-index:
15
I10-index:
16
Year
Topic
Type